'In Silico Toxicology' Network Meeting 2019
Do you use or would you like to use a computational toxicology approach for your research or your hazard assessment? Join and foster our In silico Toxicology Community in the UK and beyond and participate to our Networking Meeting 2019 which will be held on the 26th of November 2019 at the Unilever Lecture Theatre, Department of Chemistry, University of Cambridge, CB2 1EW.
The registration is free.
I am personally excited by the birth of the In silico Toxicology Community. I started my career as computational chemist and for the last 15 years as computational toxicologist. I have always found the interaction between chemists, biologists, toxicologists, cheminformatics, just to mention a few, a key factor for the successful applications of computational methods to drug discovery or toxicology. So do come along. Please give your contribution to the community. Your expertise is both valued and welcomed.
I shall present and discuss a new approach in read-across for toxicity prediction, a workflow based on chemoinformatics, which is a method applied in chemical hazard and risk assessment.
And during the day you will hear about risk assessment for consumer products (Steve Gutsell, Unilever/SEAC), drug safety and metabolism (Graham Smith, AstraZeneca), molecular initiating events (Jonathan Goodman, University of Cambridge), computational chemistry in toxicology (Tim Allen, MRC Toxicology Unit), hepatotoxicity and acute toxicity (Samar Mahmoud, University of Cambridge/Optibrium), translational toxicology (Aishling Cooke, Optibrium), adverse outcome pathway (Alun Myden, Lhasa Ltd), androgen receptor activity (Barry Hardy/Thomas Exner, EdelweissConnect) and a final discussion 'Artificial Intelligence in Computational Toxicology - What works currently, what is needed, and what will the future bring?'
To register and to see the updated agenda: http://drugdiscovery.net/tox/
We are planning to organize this as an informal annual event, hence please mark 24 November 2020 in your calendar for next year's meeting.
This event is organized by Andreas Bender (Co-Founder and Advisor at Healx Ltd) and supported by the British Toxicology Society (BTS), the Royal Society of Chemistry (RSC) CICAG Group, the Cambridge Alliance on Medicines Safety (CAMS) and Lhasa Ltd.